BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35015130)

  • 1. Diagnostic significance of reassessment of prostate biopsy specimens by experienced urological pathologists at a high-volume institution.
    Okubo Y; Yamamoto Y; Sato S; Yoshioka E; Suzuki M; Washimi K; Osaka K; Suzuki T; Yokose T; Kishida T; Miyagi Y
    Virchows Arch; 2022 May; 480(5):979-987. PubMed ID: 35015130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in disagreement with outside genitourinary pathology diagnoses at an academic center.
    Taylor C; Puzyrenko A; Iczkowski KA
    Pathol Res Pract; 2022 Aug; 236():153997. PubMed ID: 35780705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined multiple clinical characteristics for prediction of discordance in grade and stage in prostate cancer patients undergoing systematic biopsy and radical prostatectomy.
    Liu H; Tang K; Xia D; Peng E; Wang L; Chen Z
    Pathol Res Pract; 2020 Nov; 216(11):153235. PubMed ID: 33035728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer grading: the effect of stratification of needle biopsy Gleason Score 4 + 3 as high or intermediate grade.
    Fanning DM; Kay E; Fan Y; Fitzpatrick JM; Watson RW
    BJU Int; 2010 Mar; 105(5):631-5. PubMed ID: 19732053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gleason group concordance between biopsy and radical prostatectomy specimens: A cohort study from Prostate Cancer Outcome Registry - Victoria.
    Evans SM; Patabendi Bandarage V; Kronborg C; Earnest A; Millar J; Clouston D
    Prostate Int; 2016 Dec; 4(4):145-151. PubMed ID: 27995114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited Adenocarcinoma of the Prostate on Needle Core Biopsy.
    Bell PD; Teramoto Y; Gurung PMS; Yang Z; Miyamoto H
    Arch Pathol Lab Med; 2022 Apr; 146(4):469-477. PubMed ID: 35020802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of a Deep Learning Algorithm for Gleason Grading of Prostate Cancer From Biopsy Specimens.
    Nagpal K; Foote D; Tan F; Liu Y; Chen PC; Steiner DF; Manoj N; Olson N; Smith JL; Mohtashamian A; Peterson B; Amin MB; Evans AJ; Sweet JW; Cheung C; van der Kwast T; Sangoi AR; Zhou M; Allan R; Humphrey PA; Hipp JD; Gadepalli K; Corrado GS; Peng LH; Stumpe MC; Mermel CH
    JAMA Oncol; 2020 Sep; 6(9):1372-1380. PubMed ID: 32701148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concordance of "Case Level" Global, Highest, and Largest Volume Cancer Grade Group on Needle Biopsy Versus Grade Group on Radical Prostatectomy.
    Trpkov K; Sangkhamanon S; Yilmaz A; Medlicott SAC; Donnelly B; Gotto G; Shea-Budgell M
    Am J Surg Pathol; 2018 Nov; 42(11):1522-1529. PubMed ID: 30080706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grade Groups Provide Improved Predictions of Pathological and Early Oncologic Outcomes Compared with Gleason Score Risk Groups.
    Kirmiz S; Qi J; Babitz SK; Linsell S; Denton B; Singh K; Auffenberg G; Montie JE; Lane BR
    J Urol; 2019 Feb; 201(2):278-283. PubMed ID: 30195846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of concordance of Gleason score between prostate biopsy and radical prostatectomy.
    Mansouri N; Msakni I; Gargouri F; Khiari R; Bouziani A; Laabidi B
    Tunis Med; 2018 Jul; 96(7):430-436. PubMed ID: 30430487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gleason grading challenges in the diagnosis of prostate adenocarcinoma: experience of a single institution.
    Chen SD; Fava JL; Amin A
    Virchows Arch; 2016 Feb; 468(2):213-8. PubMed ID: 26563400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal Method for Reporting Prostate Cancer Grade in MRI-targeted Biopsies.
    Deng FM; Isaila B; Jones D; Ren Q; Kyung P; Hoskoppal D; Huang H; Mirsadraei L; Xia Y; Melamed J
    Am J Surg Pathol; 2022 Jan; 46(1):44-50. PubMed ID: 34115670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downgrading of biopsy based Gleason score in prostatectomy specimens.
    Treurniet KM; Trudel D; Sykes J; Evans AJ; Finelli A; Van der Kwast TH
    J Clin Pathol; 2014 Apr; 67(4):313-8. PubMed ID: 24403214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Downgrading from Biopsy Gleason 7 to Prostatectomy Gleason 6 on Biochemical Recurrence and Prostate Cancer Specific Mortality.
    Ham WS; Chalfin HJ; Feng Z; Trock BJ; Epstein JI; Cheung C; Humphreys E; Partin AW; Han M
    J Urol; 2017 Apr; 197(4):1060-1067. PubMed ID: 27847296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gleason scores of prostate biopsy and radical prostatectomy specimens over the past 10 years: is there evidence for systematic upgrading?
    Smith EB; Frierson HF; Mills SE; Boyd JC; Theodorescu D
    Cancer; 2002 Apr; 94(8):2282-7. PubMed ID: 12001128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of prostate health index to predict Gleason score upgrading and high-risk prostate cancer in radical prostatectomy specimens.
    Kim H; Jung G; Kim JH; Byun SS; Hong SK
    Sci Rep; 2021 Aug; 11(1):17447. PubMed ID: 34465825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens.
    Cheng L; Poulos CK; Pan CX; Jones TD; Daggy JK; Eble JN; Koch MO
    J Urol; 2005 Sep; 174(3):898-902. PubMed ID: 16093983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study.
    Bulten W; Pinckaers H; van Boven H; Vink R; de Bel T; van Ginneken B; van der Laak J; Hulsbergen-van de Kaa C; Litjens G
    Lancet Oncol; 2020 Feb; 21(2):233-241. PubMed ID: 31926805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The modified International Society of Urological Pathology system improves concordance between biopsy and prostatectomy tumour grade.
    Hennes DMZB; Sewell J; Kerger M; Hovens CM; Peters JS; Costello AJ; Ryan A; Corcoran NM
    BJU Int; 2021 Dec; 128 Suppl 3():45-51. PubMed ID: 34310033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
    Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL
    BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.